Today is Monday, March 22nd, what to note a day about a popular spring break location

now declaring a state of emergency, and why protesters gathered over the weekend in

several major U.S. cities. Also, who made a surprise trip to Afghanistan as the Biden

administration faces an upcoming deadline to decide whether to withdraw U.S. troops?

Plus, will former President Trump launch his own social network?

It's possible. A bumpy start for March madness, while this year's summer Olympics

faces another big shake-up, and which country was just named the happiest in the world.

Welcome, welcome to The Newsworthy, all the day's news in around 10 minutes.

Fast, fair, fun, and on the go. I'm Air Commandy, thanks so much for being here.

You're ready? Let's do this!

There's new data out today about another COVID-19 vaccine, and it's promising.

The findings of a large U.S. trial show the vaccine developed by AstraZeneca and the University

of Oxford is 100% effective in preventing severe illness and hospitalization from COVID-19,

and 79% effective in preventing any COVID-19 symptoms. The AstraZeneca vaccine, though,

is not yet authorized here in the U.S. That said, these early findings from the U.S. study

will be part of the data the company will give to the FDA, likely in the coming weeks to try and

get the green light here in America. Already, this type of vaccine has been authorized in more

than 50 other countries, though there has been some recent concerns after reports of blood

clots in some vaccinated people. That said, Europe's drug regulator says the shot is both safe and

effective, although they could not rule out that it is connected to two very rare types of clots.

Today, AstraZeneca added, an independent board found no safety concerns connected to the shot.

Stay tuned.

...